ページ14 - 最高の超音波検査医師 - トップ503名の医師

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Roy Mashiach, MD, is the Director of Gynecology at Sheba Medical Center. He is a leading expert in minimally invasive gynecologic surgery with over 30 years of experience. He focuses on laparoscopic and hysteroscopic hysterectomy. He also performs myoma removal, treats endometriosis, and offers fertility‑preserving procedures.

Recognition and roles: Named to Forbes Israel’s Best Doctors. Recipient of the Daniel F. Kott Award (AAGL). Chairman of the Israeli Society of Gynecological Endoscopy. Director of the Gynecologic Simulation Unit (M.S.R.). Clinical Associate Professor at Tel Aviv University. Training: MD from Tel Aviv University. Specialization at Lis Maternity & Women’s Hospital. Fellowship in Advanced Endoscopy at Université d’Auvergne.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. José Miguel Esteban López-Jamar is a gastroenterologist. He has led the Digestive Endoscopy and Digestive Diseases Units at Hospital Ruber Internacional since 2007. He has more than 20 years of experience. He is a Spanish pioneer in endoscopic ultrasound (EUS). His work covers diagnostic and interventional endoscopy. He uses innovative, minimally invasive techniques for complex gastrointestinal disease.

He was Head of Endoscopy (2008–2012) and Head of Endoscopic Innovation (2012–2014) at Hospital Clínico San Carlos. He completed international training at AMC Amsterdam, Institut Paoli-Calmettes in Marseille, and Zhongshan Hospital in Shanghai. He holds an MD and a PhD from the Complutense University of Madrid. He is a specialist in gastroenterology. He takes part in multicenter European studies and clinical trials. He is a member of SEPD, SEED, and ESGE.

Somjet Tosamran, MD, is a neurologist. Dr. Tosamran is a fellow in epilepsy at the Neurology Division, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand (2024–present). Dr. Tosamran completed a neurology residency at the same hospital (2021–2024). Earlier training includes internships at Charoenkrung Pracharak Hospital and Sakaeo Crown Prince Hospital.

Accreditations and education: Neurologist certification, King Chulalongkorn Memorial Hospital (2024). Master of Science in Internal Medicine, Faculty of Medicine, Chulalongkorn University (2024). Doctor of Medicine, First Class Honors, Faculty of Medicine, Chulalongkorn University (2018).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

フェルリッチ博士は、彼の専門分野でのリーディングスペシャリストです。フェルリッチ教授は1998年にウィーンでの医学学位を取得しました。2000年から2006年の間、彼はウィーン総合病院で内科のインターンシップを完了しました。2006年から2008年まで、医師はウィーン総合病院で胃腸病学および肝臓病学の追加の専門訓練を受け、2008年から2010年まで - 内部蘇生の専門家としても訓練されました。

研究賞と奨学金: 

• ベストアブストラクト賞 UEGW 2003, 2005, 2008, 2009, 2010, 2012 

• ÖGGH内視鏡グループのポスター賞 2003 

• ÖGGHのフェリング賞 2006 •ベストナショナルアブストラクトUEGW 2010（ノミネート） 

• ÖGGHによる「消化器病学におけるUEGWライジングスター」2012の全国候補 

• オーストリア中央銀行2005周年記念基金 

• オーストリア内科学会の2011年シュコダ賞 

トレーニングと臨床作業: 

• 1992-1998 ウィーン大学での医学研究、UCLA（1ヶ月）、ロサンゼルスとペンシルベニア大学、フィラデルフィア（3ヶ月）での研修を含む 

• 1999-2000 胃腸病学/インターベンショナル内視鏡部門の研究助手 

• 2000-2006 内科の専門家としての訓練 

• 2006-2008 胃腸病学および肝臓病学の追加専門家 

• 2008-2010 内部集中治療の追加専門家 

• 2003年にウィーン大学医学部での肝臓血行動態研究所と肝硬変のための外来診療所の設立と管理 

• 2018年にウィーンバルメルツィゲン・ブルーダー病院の内科I部門の責任者

セバスチャン・ショップマン博士は、一般および内臓外科の優れた専門家です。セバスチャン・ショップマン博士は、ウィーン医科大学の手術大学クリニックの一般外科部門の外科医であり、胃と食道の手術の作業チームを率いています。彼はまた、ウィーンの総合がんセンター（CCC）の胃食道腫瘍ユニット（CCC-GET）の責任者でもあります。ショップマン博士は、240以上の専門記事の著者です。

 職歴: 

• 2014年からオーストリア外科腫瘍学会の総書記 

• 2013年からウィーン総合がんセンター（CCC-GET）、ウィーン医科大学の胃食道がんユニットのコーディネーター 

• 10/2014 ASOコンレス2014の会長

• 2012年4月よりウィーン医科大学手術部門の上部消化管サービスの責任者 

• 2012年からウィーン医科大学の手術機能検査部門の責任者, 手術部門 

• 2010年2月以来、ウィーン医科大学の外科研究ラボの上部消化管研究グループの主任研究者 

• 2009 – 2011 ウィーンオフィスの欧州健康品質学会（ESQH）のディレクター 

• 10/2008 – 2/2009 プリンスコートメディカルセンター（クアラルンプール）のコンサルタント、ウィーン国際医科大学 

• 2007年から上部消化管手術の専門家 

• 2006年以降、ウィーン医科大学の手術部門の准教授 

• ウィーン医科大学 

• 2001 – 2007 ウィーン医科大学手術部門のフェロー 

• 2000 – 2001 IMP – ウィーン分子病理研究所にて学外で博士号取得 

• 1999 – 2000 ウィーン医科大学の病理学臨床研究所のフェロー 

コンサルティングエディターとして: • Annals of Surgical Oncology, Journal of Leucocyte Biology, Acta Biologica Hungarica, British Journal of Cancer, British Journal of Surgery, Oncology, Deutsche Forschungsgemeinschaft (DFG), British Journal of Oncology, BMC Cancer, Cell and Molecular Life Science, World Journal of Surgical Oncology, Breast Care, European Journal of surgical Oncology, Journal for Cellular and Molecular Biology, • Journal of Leucocyte Biologyコンサルティングエディター、European Journal of Surgical Oncologyの副編集長、European Surgeryのセクションエディター

Dr. Sung-ho Ahn is a specialist in obstetrics and gynecology.

He is the Director of the Family Birth Center at Seoul Miz Hospital. He previously led the Department of Obstetrics and Gynecology at Seoul Red Cross Hospital. He also served as an obstetrics and gynecology specialist at Seoul Paik Hospital.

He is an adjunct professor at Seoul Paik Hospital. He has taught as a clinical instructor in obstetrics and gynecology at Asan Medical Center and Ulsan University Hospital.

Professional memberships: Korean Society of Obstetrics and Gynecology; Korean Society of Maternal-Fetal Medicine.

Dr. Hyunmi Park is an OB/GYN specialist in the Department of Obstetrics. She completed her internship at Hanjeon Hospital. She then worked as an OB/GYN specialist at Hanil General Hospital. She later served as Head of the Department of Obstetrics and Gynecology at Womenpia Women’s Hospital and at Lucina Miz Hospital.

She is a member of the Korean Society of Obstetrics and Gynecology, the Korean Society of Ultrasound in Obstetrics and Gynecology, and the Korean Society of Maternal Fetal Medicine.

Dr. Do‑young Jeong is an obstetrician‑gynecologist focused on minimally invasive, single‑port, and robotic surgery. Dr. Jeong completed an internship at Seoul National University Hospital. Dr. Jeong completed residency and graduate training at Korea University. Dr. Jeong then completed a fellowship in gynecologic oncology at the National Cancer Center, focusing on uterine and ovarian disease. Dr. Jeong served as director and chief medical officer at MizMedi Hospital and Incheon Sejong Hospital. Dr. Jeong later served as vice president at Dongtan Jeil Hospital. Dr. Jeong is a Clinical Professor at Kyung Hee University Hospital at Gangdong and an Adjunct Professor at Korea University. Dr. Jeong also serves on expert committees for KSGO, MOHW, MFDS, and KHIDI.

Professional memberships include the Korean societies for obstetrics and gynecology, gynecologic endoscopy, gynecologic robotic surgery, and reproductive medicine, as well as ISUOG. Dr. Jeong holds patents for single‑port surgical devices, including a camera, access ring, and irrigation system. Honors include the Korea University Outstanding Resident Award and the KSGE Best Poster Award. Dr. Jeong was first author of SCI‑indexed papers in 2013 and 2014. From 2023 to 2025, Dr. Jeong led studies on da Vinci SP myomectomy and hysterectomy, and on HIFU.

Professor Marek Ehrlich is a cardiac surgeon at University Hospital Vienna. He has led the hospital’s aneurysm program since 2010. He graduated from the Medical University of Vienna and specializes in cardiac surgery. He has also trained internationally at Stanford, Birmingham, Houston, and Mount Sinai Hospital in New York.

Dr. Ehrlich has published over 100 scientific articles on aneurysm surgery. He has led research in neuroprotection and endovascular techniques. He has received several international awards for his work. Dr. Ehrlich often speaks at major global conferences. He is fluent in English and Polish.

Dr. Sitanan Panunumpa is a reproductive medicine specialist and the medical director of Siam Fertility at Kaset-Nawamin.

Credentials: M.D. (Khon Kaen University). Residency in Obstetrics and Gynecology (Khon Kaen Hospital). Board-certified in Reproductive Medicine (Faculty of Medicine, Ramathibodi Hospital). Master’s in Biotechnology of Human Assisted Reproduction and Embryology (IVI-University of Valencia, ADEIT). Member of ASRM, ESHRE, and ASPIRE.

Clinical activity: Performs over 300 IVF/ICSI-ET/FET cycles per year. Performs over 200 gynecologic laparoscopic surgeries per year. Experience includes Siam Fertility at Kaset-Nawamin (2022-2026), Siam Fertility at Phayathai (2021-2022), Synphat-Seriruk (2019-2022), and OB-GYN at Sikarin Hospital (2013-2017).

Dr. Tharaporn Russameecharoen is an obstetrician-gynecologist. She received her MD in 1997 from Thammasat University. She completed specialty training in obstetrics and gynecology at Siriraj Hospital from 2001 to 2003.

She has been an obstetrician-gynecologist at Yanhee International Hospital since 2008. She worked at Hua Chiew Hospital in Bangkok from 2003 to 2004. Her recent training includes a Fresh Cadaver Hands-on Workshop in Aesthetic Gynecology in 2024. She completed ACLS in 2023 with Sierre International Medical Training Solutions Co., Ltd. She attended the SIOG/RTCOG annual conferences from 2017 to 2023.

She is a member of the Royal College of Obstetricians and Gynecologists of Thailand, the Medical Council of Thailand, and the Thai Society of Aesthetic Gynecology (TSAG).